TravelMedEvidence. Expertise. Safer travel.
/
← All insights
Data insight

Climate change and dengue: what the models show

A look at how temperature and rainfall projections are reshaping where vector-borne disease risk will fall.

Dr. Marco Seneghini, MD·Apr 15, 2026·7 min read
Cracked, drought-stricken earth

Vector-borne disease risk is unusually sensitive to climate because the mosquito, the pathogen, and the biting rate all respond to temperature. Modeling studies converge on a consistent picture: the map of risk is shifting, not simply growing.

Why temperature matters so much

  • Extrinsic incubation period. Warmer temperatures let the virus replicate faster inside the mosquito, so a higher fraction of mosquitoes become infectious within their lifespan.
  • Biting frequency rises with temperature up to a thermal optimum (around 29 °C for Aedes aegypti–borne dengue).
  • The relationship is hump-shaped: beyond the optimum, transmission falls. Some currently hot regions may become less suitable while cooler regions become more suitable.

What the projections suggest

  • A net expansion of the population at risk for dengue and an extension of transmission seasons in temperate zones.
  • Altitude shifts: highland areas previously protected by cool temperatures (parts of the East African and Andean highlands) face rising suitability.
  • For malaria, the picture is more mixed — some regions gain suitability, others lose it as they exceed thermal limits or dry out.

How to read this as a traveler

Models describe suitability, not certainty. Local control, urbanization, and surveillance heavily modify real risk. The practical takeaway: check current, season-specific guidance for your destination rather than relying on historical "this region is/ isn't risky" assumptions.

Bottom line: climate is widening and shifting the risk map. Static mental models age badly — current data beats reputation.

#climate#modeling#dengue#malaria

Related insights

Expert analysisWolbachia and dengue control: where are we in 2026?A review of the evidence behind Wolbachia-based mosquito programs and what large-scale deployment means for travelers.Paper reviewQdenga real-world effectiveness and safety: new dataHow the TAK-003 dengue vaccine is performing outside trials — and where it fits for travelers.Public healthWhy dengue is expanding beyond the tropicsAutochthonous dengue in southern Europe is no longer a curiosity. What's driving the spread, and what it means for trip planning.